Patterns of use, harm reduction strategies, and their relation to risk behavior and harm in recreational ketamine users

References

• Corazza O, Assi S, F. Schifano From “Special K” to “Special M”: the evolution of the recreational use of ketamine and methoxetamine. CNS Neurosci Ther 2013;19(6):454–460.
   PubMed Web of Science ®Google Scholar
• Morgan CJ, Curran HV. Independent scientific committee on drugs. Ketamine use: a review. Addiction 2012;107:27–38.
   PubMed Web of Science ®Google Scholar
• Morgan CJ, Muetzelfeldt L, Curran HV. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction 2010;105:121–133.
   PubMed Web of Science ®Google Scholar
• Chen WJ, Ting TT, Chang CM, Liu YC, Chen CY. Ketamine use among regular tobacco and alcohol users as revealed by respondent driven sampling in Taipei: prevalence, expectancy, and users’ risky decision making. J Food Drug Anal 2013;21:S102–S105.
   Google Scholar
• Wood DM, Measham F, Dargan PI. “Our favourite drug”: prevalence of use and preference for mephedrone in the London night-time economy 1 year after control. J Subst Use 2012;17:91–97.
   Web of Science ®Google Scholar
• Ravn S, Demant J. Prevalence and perceptions of ketamine use among Danish clubbers: a mixed-method study. Nordisk Alkohol Nark 2012;29:397–412.
   Google Scholar
• Fernández-Calderon F, Lozano OM, Vidal C, Gutiérrez J, Vergara E, González-Saiz F, Energy Control Team. Polysubstance use patterns in underground rave attenders: a cluster analysis. J Drug Educ 2011;41:183–202.
   PubMed Web of Science ®Google Scholar
• Winstock A. Global drug survey. Available from: http://www.globaldrugsurvey.com/ [last accessed 27 Oct 2015].
   Google Scholar
• Pal R, Balt S, Erowid E, Erowid F, Baggott MJ, Mendelson J, Galloway GP. Ketamine is associated with lower urinary tract signs and symptoms. Drug Alcohol Depend 2013;132:189–194.
   PubMed Web of Science ®Google Scholar
• Kalsi SS, Wood DM, Dargan PI. The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threats J 2011;4:7107.
   PubMedGoogle Scholar
• Winstock AR, Mitcheson L, Gillatt DA, Cottrell AM. The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int 2012;110:1762–1766.
   PubMed Web of Science ®Google Scholar
• Muetzelfeldt L, Kamboj SK, Rees H, Taylor J, Morgan C, Curran HV. Journey through the K-hole: phenomenological aspects of ketamine use. Drug Alcohol Depend 2008;95:219–229.
   PubMed Web of Science ®Google Scholar
• Morgan CJ, Muetzelfeldt L, Curran HV. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls. Addiction 2009;104:77–87.
   PubMed Web of Science ®Google Scholar
• Dillon P, Copeland J, Jansen K. Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend 2003;69:23–28.
   PubMed Web of Science ®Google Scholar
• Tang WK, Morgan CJ, Lau GC, Liang HJ, Tang A, Ungvari GS. Psychiatric morbidity in ketamine users attending counseling and youth outreach services. Subst Abuse 2014;14:67–74.
   Google Scholar
• Copeland, J, Dillon P. The health and psycho-social consequences of ketamine use. Int J Drug Policy 2005;16:122–131.
   Web of Science ®Google Scholar
• Linden A, Kite BA, Braitman AL, Henson JM. Protective behavioral strategy use and motivations for drinking: exploring alternatives to drinking strategies. Addict Behav 2014;39:469–472.
   PubMed Web of Science ®Google Scholar
• Haines MP, Barker G, Rice RM. The personal protective behaviors in college student drinkers: evidence of indigenous protective norms. J Am Coll Health 2006;55:69–75.
   PubMed Web of Science ®Google Scholar
• Martens MP, Taylor KK, Damann KM, Page JC, Mowry ES, Cimini MD. Protective behavioral strategies when drinking alcohol and their relationship to negative alcohol-related consequences in college students. Psychol Addict Behav 2004;18:390–393.
   PubMed Web of Science ®Google Scholar
• Jacinto C, Duterte M, Sales P, Murphy S. Maximising the highs and minimising the lows: harm reduction guidance within ecstasy distribution networks. Int J Drug Policy 2008;19:393–400.
   PubMed Web of Science ®Google Scholar
• Kelly BC. Mediating MDMA-related harm: preloading and post-loading among ecstasy-using youth. J Psychoactive Drugs 2009;41:19–26.
   PubMed Web of Science ®Google Scholar
• Panagopoulos, I, Ricciardelli, LA. Harm reduction and decision making among recreational ecstasy users. Int J Drug Policy 2005;16:54–64.
   Web of Science ®Google Scholar
• Zuffa G. Cocaine: towards a self-regulation model. Amsterdam: Transnational Institute; 2014.
   Google Scholar
• Fernández-Calderon F, Lozano OM, Rojas-Tejada AJ, Bilbao I, Vidal C, Vergara E, Gonzalez-Saiz, F. Harm reduction behaviors among young polysubstance users at raves. Subst Abus 2014;35:45–50.
   PubMed Web of Science ®Google Scholar
• Hunt G, Evans K, Moloney M, Bailey N. Combining different substances in the dance scene: enhancing pleasure, managing risk and timing effects. J Drug Issues 2009;39:495–522.
   PubMed Web of Science ®Google Scholar
• Fricker RD, Schonlau M. Advantages and disadvantages of Internet research surveys: evidence from the literature. Field Methods 2002;14:347–367.
   Google Scholar
• Kalogeraki S. On the benefits and constraints of the web-based illicit drug survey. Int J Interdis Soc Sci 2011;6:239–252.
   Google Scholar
• Reynaud-Maurupt C, Bello PY, Akoka S, Toufik A. Characteristics and behaviors of ketamine users in France in 2003. J Psychoactive Drugs 2007;39:1–11.
   PubMed Web of Science ®Google Scholar
• Akram G, Galt M. A profile of harm-reduction practices and co-use of illicit and licit drugs amongst users of dance drugs. Drug Educ Prevent Policy 1999;6:215–225.
   Web of Science ®Google Scholar
• Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J. The SDS: psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995;90:607–614.
   PubMed Web of Science ®Google Scholar
• Liang HJ, Lau CG, Tang A, Chan F, Ungvari GS, Tang WK. Cognitive impairments in poly-drug ketamine users. Addict Behav 2013;38:2661–2666.
   PubMed Web of Science ®Google Scholar
• Uosukainen H, Tacke U, Winstock AR. Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users. Int J Drug Policy 2015;26:78–83.
   PubMed Web of Science ®Google Scholar
• Morgan CJ, Curran HV. Acute and chronic effects of ketamine upon human memory: a review. Psychopharmacology (Berl) 2006;188:408–424.
   PubMed Web of Science ®Google Scholar
• Cheng WC, Ng KM, Chan KK, Mok VK, Cheung BK. Roadside detection of impairment under the influence of ketamine: evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine. Forensic Sci Int 2007;170:51–58.
   PubMed Web of Science ®Google Scholar
• Wong OF, Tsui KL, Lam TS, Sze NN, Wong SC, Lau FL, Liu SH. Prevalence of drugged drivers among non-fatal driver casualties presenting to a trauma centre in Hong Kong. Hong Kong Med J 2010;16:246–251.
   PubMedGoogle Scholar
• Tang WK, Liang HJ, Lau CG, Tang A, Ungvari GS. Relationship between cognitive impairment and depressive symptoms in current ketamine users. J Stud Alcohol Drugs 2013;74:460–468.
   PubMed Web of Science ®Google Scholar
• Skarupova K. Computer-assisted and online data collection in general population surveys. Technical Report. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2014. Available from: http://www.emcdda.europa.eu/publications/technical-reports/online-data-collection-gps [last accessed 10 Oct 2014].
   Google Scholar